Opella Egypt leads with purpose at Africa Health ExCon
Opella Egypt participated as a Gold Sponsor at Africa Health ExCon 2025, co-hosted by Africa Centres for Disease Control and Prevention (Africa CDC), Africa's leading healthcare event. The conference welcomed over 60,000 attendees from 150+ countries, held under the patronage of President Abdel Fattah Al-Sisi.
'Towards Sustainable Healthcare' session, held by Opella on June 25, focused on Opella's sustainability, B Corp certification and self-care vision. At the heart of the session was a panel on e-Labelling, a joint ambition by Opella and the Egyptian Drug Authority (EDA) to cut waste and expand access to reliable health information. The takeaway was simple: Digital, eco-friendly tools aren't optional. They're essential for a smarter, more sustainable future.
Opella leaders, experts from the World Health Organization (WHO), the EDA, South Africa's regulatory bodies, and the Global Self-Care Federation (GSCF) contributed valuable insights. The message was clear: Long-term impact starts with informed choices, stronger health literacy, and is bolstered by collaboration. Opella achieved a new milestone on its journey to deliver responsible self-care for people and planet. Certified by B Lab, B Corp recognizes companies that meet rigorous standards of social and environmental performance, transparency, and accountability.
Marissa Saretsky, Chief Sustainability Officer:
'We are proud to be the first global consumer healthcare company to achieve B Corp Certification, reflecting our commitment to sustainability and accountability. Our strategy towards a healthier planet and society focuses on decarbonizing our operations and value chain, embedding circularity, driving health literacy and supporting surrounding communities through NGO partnerships. We look forward to working with all partners across the sector to make sustainable self-care second nature.'
Josephine Fubara, Chief Science Officer:
'e-Labeling puts more power in the hands of consumers. It empowers consumers by making self-care easier, more accessible, and sustainable—while simplifying healthcare for everyone. To realize its full potential, we need early, open collaboration across regulators, industry, healthcare professionals, and patients.'
Feirouz Ellouze, General Manager (AMET):
'Opella's presence at the conference highlights our commitment to sustainable healthcare systems. We are a dedicated global self-care leader, ready to meet the health needs of consumers. Our independence allows us to innovate faster and stay focused on our mission: making self-care as simple as it should be – for everyone.'
The EDA has been leading a multi-phase e-Labelling shift to modernize medicine information and boost sustainability. Launched in 2022, The initiative, launched in 2022, replaces paper leaflets with QR-linked digital formats, starting with hospital-use products. Now in its second phase, it supports health literacy, cuts paper waste, and sets the stage for full digital integration using global standards.
By digitizing the 60 million leaflets provided annually by Opella Egypt alone, we could save 300 tonnes of carbon emissions and protect 5,400 trees. Recognizing the significance of collaboration and active participation among various stakeholders, Opella is committed to supporting initiatives that facilitate this transition and drive sustainable change.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily News Egypt
18 hours ago
- Daily News Egypt
Opella Egypt leads with purpose at Africa Health ExCon
Opella Egypt participated as a Gold Sponsor at Africa Health ExCon 2025, co-hosted by Africa Centres for Disease Control and Prevention (Africa CDC), Africa's leading healthcare event. The conference welcomed over 60,000 attendees from 150+ countries, held under the patronage of President Abdel Fattah Al-Sisi. 'Towards Sustainable Healthcare' session, held by Opella on June 25, focused on Opella's sustainability, B Corp certification and self-care vision. At the heart of the session was a panel on e-Labelling, a joint ambition by Opella and the Egyptian Drug Authority (EDA) to cut waste and expand access to reliable health information. The takeaway was simple: Digital, eco-friendly tools aren't optional. They're essential for a smarter, more sustainable future. Opella leaders, experts from the World Health Organization (WHO), the EDA, South Africa's regulatory bodies, and the Global Self-Care Federation (GSCF) contributed valuable insights. The message was clear: Long-term impact starts with informed choices, stronger health literacy, and is bolstered by collaboration. Opella achieved a new milestone on its journey to deliver responsible self-care for people and planet. Certified by B Lab, B Corp recognizes companies that meet rigorous standards of social and environmental performance, transparency, and accountability. Marissa Saretsky, Chief Sustainability Officer: 'We are proud to be the first global consumer healthcare company to achieve B Corp Certification, reflecting our commitment to sustainability and accountability. Our strategy towards a healthier planet and society focuses on decarbonizing our operations and value chain, embedding circularity, driving health literacy and supporting surrounding communities through NGO partnerships. We look forward to working with all partners across the sector to make sustainable self-care second nature.' Josephine Fubara, Chief Science Officer: 'e-Labeling puts more power in the hands of consumers. It empowers consumers by making self-care easier, more accessible, and sustainable—while simplifying healthcare for everyone. To realize its full potential, we need early, open collaboration across regulators, industry, healthcare professionals, and patients.' Feirouz Ellouze, General Manager (AMET): 'Opella's presence at the conference highlights our commitment to sustainable healthcare systems. We are a dedicated global self-care leader, ready to meet the health needs of consumers. Our independence allows us to innovate faster and stay focused on our mission: making self-care as simple as it should be – for everyone.' The EDA has been leading a multi-phase e-Labelling shift to modernize medicine information and boost sustainability. Launched in 2022, The initiative, launched in 2022, replaces paper leaflets with QR-linked digital formats, starting with hospital-use products. Now in its second phase, it supports health literacy, cuts paper waste, and sets the stage for full digital integration using global standards. By digitizing the 60 million leaflets provided annually by Opella Egypt alone, we could save 300 tonnes of carbon emissions and protect 5,400 trees. Recognizing the significance of collaboration and active participation among various stakeholders, Opella is committed to supporting initiatives that facilitate this transition and drive sustainable change.
Al-Ahram Weekly
4 days ago
- Al-Ahram Weekly
AOI, China's XGY partner to localize medical devices manufacturing in Egypt - Health
The Arab Organization for Industrialization (AOI) and Chinese company XGY Medical Devices inked a partnership agreement on Wednesday to establish the Arab-Chinese Medical Industries Company for localizing medical device manufacturing. The signing took place on the sidelines of the fourth Africa Health ExCon 2025's opening, organized by the Egyptian Authority for Unified Procurement (UPA) from 24 to 27 June under the theme: "Innovation and Independence: Harnessing Artificial Intelligence and Local Manufacturing to Strengthen African Health Systems." Major General Mokhtar Abdel-Latif, chairman of AOI's board of directors, and Jiao Da Tian, chairman of XGY Medical Devices, signed the partnership. Egyptian Minister of Health Khaled Abdel-Ghaffar also witnessed the signing. In an AOI statement, Abdel-Latif said the agreement includes establishing a joint company to localize the medical device industry. The company will start with diagnostic and therapeutic radiology equipment in the first phase, leveraging AOI's advanced manufacturing capabilities. He added that the goal is to reduce the cost of imported technological components by designing and manufacturing them within AOI for the first time in Egypt, achieving complete localization of this vital industry. He further explained that the cooperation will include specialized training programmes for engineers and technicians working in the new joint company, along with providing maintenance services and spare parts. Abdel-Latif affirmed the AOI's commitment to forming strategic and productive partnerships with the global Chinese company to expand cooperation in the medical device manufacturing field according to international quality standards. The partnership aims to increase market access, meet local demand, reduce reliance on imports, and open export channels to African, Arab, and global markets at competitive prices. For his part, XGY's chairman expressed his pride in collaborating with the AOI. "This partnership reflects strong confidence in AOI's advanced manufacturing capabilities," he stressed. He further emphasized XGY's commitment to fully transferring its technology to Egypt through the joint venture with AOI. "This would enhance cooperation and expand export opportunities by capitalizing on Egypt's successful investment climate," he added. XGY Medical Devices, established in 1998, is a high-end medical equipment manufacturing project jointly constructed by Zhejiang Xingaoyi Medical Equipment Co., Ltd., Shandong Longzhiyuan Medical Equipment Co., Ltd., and Junan Caijin Group in 2022. The company integrates research and development, production, sales, and after-sales of magnetic resonance equipment. The partnership follows a cooperation protocol signed in May with Philips to localize the medical device industry and boost Egypt's capacity in biomedical engineering. The protocol includes feasibility studies for domestic production, development of device components, and establishment of a specialized biomedical engineering centre for knowledge transfer. In 2023 alone, Philips, a global tech company, made 607 medical technology patent applications, becoming the second largest applicant in the medical technology field in the European Patent Office (EPO) index. "ExCon 2025 will witness the signing of 15 agreements and contracts in the fields of medical tourism for African countries, as well as strategic partnerships to reform healthcare systems in several African nations," General Authority for Healthcare (GAH) Chairman Ahmed El-Sobky said on the sidelines of the conference. Follow us on: Facebook Instagram Whatsapp Short link:
Egypt Today
4 days ago
- Egypt Today
Health Min.: Egypt produces 91% of medicines locally, leads the pharmaceutical industry in Africa
Pharmacy - file CAIRO - 25 June 2025: Egyptian Minister of Health and Population and Deputy Prime Minister for Human Development, Dr. Khaled Abdel Ghaffar, emphasized that the importance of the African Medical Conference and Exhibition "Health Africa" stems from President Abdel Fattah El-Sisi's directive to prioritize various state sectors and focus on industry and its localization in Egypt. During a special interview with Extra News Channel, Khaled Abdel Ghaffar added that the ventilators at the exhibition are entirely locally manufactured, in addition to the television scans, and there are indications of the manufacturing of MRI and CT scan devices, as well as surgical consumables, with industrial capabilities considered the strongest on the continent. Khaled Abdel Ghaffar pointed out that the Egyptian state, under the directives of President El-Sisi, has been establishing a massive information base and infrastructure for eight years, containing everything related to the Egyptian citizen, some of which includes patient-specific health information. Consequently, applications for early and accurate diagnosis, the development of new types of medicine using artificial intelligence, and telemedicine are being developed. All of this informs decision-makers with the massive data generated through the 100 Million Health Initiative and presidential initiatives. Khaled Abdel Ghaffar explained that Egypt is the first and only country in Africa to have 91 percent of its pharmaceutical needs manufactured locally.
